Andy Cecere and Dilip Shanghvi represent two very different paths to business leadership. Cecere built his reputation through a decades-long career in American banking, rising to become chairman and CEO of U.S. Bancorp. Shanghvi, meanwhile, built Sun Pharmaceutical Industries from a small 1983 venture into a global pharmaceutical company. Both are highly successful executives, but their careers, industries, backgrounds and fortunes tell distinctly different stories.
Andy Cecere and Dilip Shanghvi – Quick Bio Table
| Profile Detail | Andy Cecere | Dilip Shanghvi |
|---|---|---|
| Full Name | Andrew J. Cecere | Dilip Shantilal Shanghvi |
| Known As | Andy Cecere | Dilip Shanghvi |
| Date of Birth | 1961* | October 1, 1955 |
| Age (2026) | 65 | 70 |
| Net Worth (Estimated) | Approximately $50–70 million* | Approximately $26.5 billion according to Forbes’ August 2026 real-time estimate |
| Birthplace | Chicago, Illinois, USA | Amreli, Gujarat, India |
| Nationality | American | Indian |
| Profession | Banking executive and corporate leader | Pharmaceutical entrepreneur and business executive |
| Famous For | Former Chairman and CEO of U.S. Bancorp/U.S. Bank | Founder and Executive Chairman of Sun Pharmaceutical Industries |
| Career Began | Joined U.S. Bank in 1985 | Founded Sun Pharma in 1983 |
| Current Career Status | Former U.S. Bancorp executive chairman; retired from the board in 2026 | Executive Chairman of Sun Pharmaceutical Industries |
| Major Industry | Banking and financial services | Pharmaceuticals and healthcare |
| Parents | Joe (Giuseppe) Cecere and Maria Cecere | Shantilal Shanghvi and mother from the Shanghvi family |
| Siblings | Two brothers: Dominic and Joe | Detailed sibling information is not consistently documented |
| Spouse | Private/not sufficiently documented in authoritative sources | Vibha Shanghvi |
| Children | Private/not sufficiently documented | Aalok Shanghvi and Vidhi Shanghvi |
| Education | University of St. Thomas; MBA from University of Minnesota Carlson School of Management | B.Com., University of Calcutta |
| Early Career | Financial analyst before joining U.S. Bank | Worked in his father’s pharmaceutical distribution business |
| Major Company | U.S. Bancorp / U.S. Bank | Sun Pharmaceutical Industries |
| Major Business Milestone | Rose through CFO, COO, president, CEO and chairman roles | Built Sun Pharma and completed the major Ranbaxy acquisition |
| CEO Role | Became U.S. Bancorp CEO in 2017 | Founder and long-term leader of Sun Pharma |
| Chairman Role | Chairman and CEO; later executive chairman | Executive Chairman, Sun Pharma |
| Career Length | Nearly four decades with U.S. Bank | More than four decades in pharmaceuticals |
| Height | Not reliably publicly documented | Not reliably publicly documented |
| Weight | Not reliably publicly documented | Not reliably publicly documented |
| Hair Color | Not officially documented | Not officially documented |
| Eye Color | Not officially documented | Not officially documented |
| Hobbies | Limited reliable public information | Enjoys Hollywood action films and family time |
| No verified personal account confidently established | No verified personal account confidently established | |
| Marital Status | Private/not sufficiently documented | Married |
| Family Background | Son of Italian immigrants; family later moved to Minnesota | Grew up in a pharmaceutical-trading family |
| Business Beginning | Entered banking after financial-analysis experience | Started Sun Pharma in 1983 with money borrowed from his father |
| Major Acquisition/Expansion | Helped engineer U.S. Bank mergers and acquisitions | Ranbaxy acquisition, completed in 2015 |
| Major Recognition | Recognized for banking leadership and community involvement | Padma Shri (2016) plus numerous business honors |
| Known Leadership Style | Banking, financial management, risk management and organizational leadership | Entrepreneurship, pharmaceutical expansion, acquisitions and strategic growth |
| Public Profile | Primarily known in the financial and banking sector | Widely recognized as one of India’s richest entrepreneurs |
| 2026 Position | Retired from U.S. Bancorp’s board after serving as executive chairman | Executive Chairman of Sun Pharma |
| Legacy | Nearly 40 years of leadership at one of America’s major banking organizations | Building Sun Pharma into a major global pharmaceutical company |
| Key Strength | Banking leadership and financial expertise | Entrepreneurship and pharmaceutical business expansion |
| Estimated Wealth Source | Banking compensation, investments and equity holdings | Sun Pharmaceutical Industries and related investments |
| Overall Career | Banking executive | Pharmaceutical billionaire entrepreneur |
Andy Cecere and Dilip Shanghvi Images
